Monsanto (MON): FQ4 EPS of -$0.22 beats by $0.05. Revenue of $2.25B (+15.1% Y/Y) beats by $360M. Sees FY12 mid-teens earnings growth to a range of $3.34-$3.44 EPS, boosted by above normal business in Latin America for Q1. The Seeds and Genomics segment is expected to kick in single-digit unit growth to derive gross profit in a range of $5.7B-$5.85B for the year.
Monsanto is up over $1 premarket.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment